Medulloblastoma  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00047177: Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Completed
2
43
US
Oxaliplatin
Pediatric Brain Tumor Consortium, National Cancer Institute (NCI)
Brain and Central Nervous System Tumors
08/04
07/07
NCT00407433: Clinical Studies of Gemcitabine-Oxaliplatin

Completed
2
156
Europe
Gemcitabine (Gemzar®), Oxaliplatin (Eloxatin®)
Gustave Roussy, Cancer Campus, Grand Paris
Medulloblastoma, Central Nervous System Tumors, Neuroblastoma, Osteosarcoma
 
 

Download Options